GLIS3 Activators
GLIS3 activators, as a chemical class, would be defined by their ability to increase the activity of GLIS3 protein within the cell. This activation could occur through various mechanisms that ultimately enhance the expression, stabilization, or function of GLIS3. These compounds can act at the genetic level, influencing the transcription of the GLIS3 gene by altering chromatin structure, such as increasing histone acetylation, thus making the DNA more accessible to transcription machinery. Others might stabilize the mRNA transcript of GLIS3, thereby prolonging its existence and increasing protein translation. Some chemicals could activate GLIS3 post-translationally, by influencing the phosphorylation state of the protein, affecting its nuclear localization, or enhancing its DNA binding activity.
Each activator in this class would have a unique molecular signature that affects one or multiple points within the GLIS3-associated pathways. For instance, chemicals that modulate upstream kinases could indirectly activate GLIS3 by promoting its phosphorylation and subsequent nuclear translocation where it functions as a transcription factor. Another chemical might bind directly to GLIS3, inducing a conformational change that increases its affinity for DNA and its transcriptional activity. It's important to note that the specificity of these chemicals is vital, as nonspecific activators could affect multiple pathways and lead to off-target effects.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic acid, a metabolite of vitamin A, is known to modulate gene expression through its receptors. As GLIS3 is a transcription factor, retinoic acid could indirectly promote its activation by enhancing the transcriptional machinery or by upregulating genes that are synergistic with GLIS3’s function in beta-cell development and insulin regulation. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Lithium chloride activates the Wnt signaling pathway via inhibition of GSK-3β, which stabilizes transcription factors involved in this pathway. While direct stimulation of GLIS3 is not established, this stabilization could lead to an upregulation of gene expression patterns that might augment GLIS3-mediated transcription. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin directly stimulates adenylyl cyclase, increasing intracellular cAMP levels, which can activate PKA. PKA has the potential to influence numerous transcription factors and coactivators that could interact with GLIS3 or its target genes, potentially enhancing GLIS3 activity. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates protein kinase C (PKC) which is involved in numerous signaling cascades and can modulate the activity of various transcription factors. PKC activation may lead to alterations in the cellular milieu that could indirectly enhance GLIS3 transcriptional activity. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Resveratrol, a polyphenol found in grapes, activates SIRT1, which is involved in deacetylating transcription factors and histones, potentially altering gene expression in a manner that could support GLIS3 activation. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
Curcumin, the active compound in turmeric, modulates various signal transduction pathways, potentially affecting transcription factors and coactivators associated with GLIS3 activity. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
Sodium butyrate is a short-chain fatty acid that acts as a histone deacetylase inhibitor, which can lead to a more relaxed chromatin structure and enhance transcription. This could indirectly increase GLIS3 expression or activity by modulating the transcriptional landscape. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG, the main catechin found in green tea, has multiple cellular targets and could potentially affect transcription factor activity, including the potential indirect upregulation of GLIS3 through its broader effects on cellular signaling pathways. | ||||||
Pioglitazone | 111025-46-8 | sc-202289 sc-202289A | 1 mg 5 mg | $55.00 $125.00 | 13 | |
Pioglitazone, a PPAR-γ agonist, while primarily known for its role in improving insulin sensitivity, can also modulate transcription factor activity and gene expression, potentially affecting GLIS3 indirectly. | ||||||
Metformin | 657-24-9 | sc-507370 | 10 mg | $79.00 | 2 | |
Metformin activates AMP-activated protein kinase (AMPK), which could lead to alterations in cellular energy status and potentially modulate transcription factor activity, including GLIS3. | ||||||